Ketogenic Nutritional Composition for Traumatic Brain Injury Recovery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for traumatic brain injury (TBI) lack effective interventions to counter secondary brain damage and promote recovery, with existing ketogenic diets being unpalatable, difficult to comply with, and associated with health drawbacks.
Innovation Solution
An enteral nutritional composition comprising a lipid fraction with therapeutically effective amounts of DHA and EPA, medium-chain triglycerides, and a ketogenic ratio between 1.4:1 and 3:1, along with a protein fraction and low glycemic index carbohydrates, administered orally to promote recovery from TBI.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a classical ketogenic diet with high lipid content (4:1 ratio) is used to treat TBI, then neuroprotective effect and ketone body production are improved, but palatability deteriorates and compliance becomes difficult
Solution Approach 1:
The patent modifies the ketogenic ratio from the classical 4:1 to a lower range of 1.4:1 to 3:1, and adjusts the lipid composition to include specific amounts of DHA (1-5 wt%) and MCTs (at least 2 wt% C8 and C10). These parameter changes maintain therapeutic effectiveness while improving palatability and compliance.
Solution Approach 2:
The nutritional composition combines multiple lipid types (DHA, EPA, MCTs) with proteins and low glycemic index carbohydrates in a composite formulation. This creates a balanced diet that provides neuroprotective benefits while being more palatable and easier to comply with than pure ketogenic diets.
2Reliability
If immediate intravenous infusion of large quantities of DHA is administered after TBI, then adverse effects on brain function are reduced, but the treatment complexity and intervention intensity increase
Solution Approach 1:
The patent replaces the mechanical intervention of intravenous infusion with oral nutritional supplementation. This substitution maintains the therapeutic benefit of DHA administration while eliminating the need for complex medical equipment and hospital-based interventions.
Solution Approach 2:
The nutritional composition is designed to provide DHA and other nutrients in advance through daily supplementation, rather than attempting to reverse damage after it occurs. This preventive approach simplifies the treatment protocol while maintaining effectiveness.
3Reliability
If a ketogenic diet with restricted carbohydrates is used to minimize hyperglycemia, then plasma glucose concentrations are reduced and neuroprotection is improved, but the diet becomes unpalatable and difficult to adhere to
Solution Approach 1:
The patent allows a moderate amount of low glycemic index carbohydrates (not completely restricted) while maintaining a ketogenic ratio of 1.4:1 to 3:1. This parameter adjustment reduces hyperglycemia and improves neuroprotection while significantly improving palatability and adherence compared to classical ketogenic diets.
4Reliability
If high amounts of lipids are provided in the diet to achieve ketogenic metabolism, then ketone body production is enhanced, but the diet becomes unbalanced and associated with health drawbacks
Solution Approach 1:
The patent creates a balanced composite nutritional composition that includes lipids (providing ketone bodies), proteins (for tissue repair and neurotransmitter synthesis), and low glycemic index carbohydrates (for moderate energy and fiber). This composite approach maintains ketogenic metabolism while ensuring dietary balance and avoiding health drawbacks of extreme high-fat diets.
Solution Approach 2:
The patent specifies particular lipid compositions with DHA (1-5 wt%) and MCTs (at least 2 wt% C8 and C10) rather than just total lipid content. This localized quality control ensures that the lipid portion contributes to both ketone production and brain health without creating an unbalanced diet.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition improves neurological and sensorimotor recovery, cognitive function, and spatial memory in TBI models, reducing secondary injury and enhancing ketone body production without inducing ketosis.
Implementation Method 1
The liver can use long-chain fatty acids though to synthesise the three ketone bodies β-hydroxybutyrate, acetoacetate and acetone. These ketone bodies can under conditions enter the brain and act as a glucose substitute.
Implementation Method 2
These are used through fatty-acid oxidation in the cell's mitochondria.
Implementation Method 3
Additionally medium-chain fatty acids octanoic (C8) and heptanoic (C7) acids can cross the blood brain barrier and be used by the brain.
Implementation Method 4
These disturbances themselves result in reactive oxygen species (ROS)-mediated neurodegeneration through calcium release, glutamate toxicity, lipid peroxidation, and mitochondrial dysfunction.
Data Source
AI summary
The invention provides for an enteral nutritional composition comprising (a) a lipid fraction, (b) a digestible carbohydrate fraction and (c) a protein fraction, wherein the lipid fraction comprises therapeutically effective amounts of (i) DHA and optionally EPA, and (ii) medium-chain triglycerides, preferably at least 2 wt % C8 and C10 medium-chain triglycerides based on weight of the fatty acids; and wherein the composition has a ketogenic weight ratio between 1.4:1 and 3:1, for use in the treatment of traumatic brain injury (TBI).